Results 171 to 180 of about 21,386 (303)

Prevalence of Kaposi’s sarcoma-associated herpesvirus in Uygur and Han populations from the Urumqi and Kashgar regions of Xinjiang, China [PDF]

open access: yes, 2017
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the infectious etiologic agent associated with Kaposi’s sarcoma (KS), primary effusion lymphoma, and multicentric Castleman disease.
Cui, Meng   +8 more
core   +1 more source

Peripheral helper-T-cell-derived CXCL13 is a crucial pathogenic factor in idiopathic multicentric Castleman disease [PDF]

open access: gold, 2023
Takuya Harada   +8 more
openalex   +1 more source

TAFRO syndrome: current perspectives

open access: yesJournal of Blood Medicine, 2018
Kentaro Sakashita,1,2 Kengo Murata,2 Mikio Takamori2 1Department of Internal Medicine, Tokyo Metropolitan Matsuzawa Hospital, 2Department of Respiratory Medicine, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan Abstract: Multicentric Castleman’
Sakashita K, Murata K, Takamori M
doaj  

Clinical Characteristics and Prognosis of Pediatric Idiopathic Multicentric Castleman Disease [PDF]

open access: bronze
Yuhan Gao   +8 more
openalex   +1 more source

Castle man disease: a case report and review of the literature [PDF]

open access: yes, 2016
The Castleman disease (CD) is a rare disease of unknown etiology, characterized histologically by angiofollicular lymphoid hyperplasia. It comes in two forms, unicentric and multicentric.
Attifi, Hicham   +6 more
core   +1 more source

Successful outcome in a case of idiopathic multicentric Castleman disease with atypical lymphadenopathy and kidney injury: Diagnostic challenges and treatment approach—Case report

open access: yesSAGE Open Medical Case Reports
Idiopathic multicentric Castleman disease is a rare and complex disease characterized by systemic inflammation, lymphadenopathy, and multiorgan involvement. This case report presents a 66-year-old Chinese man with idiopathic multicenter Castleman disease
Dilina Yalikun   +8 more
doaj   +1 more source

Update and new approaches in the treatment of Castleman disease

open access: yesJournal of Blood Medicine, 2016
Kah-Lok Chan,1 Stephen Lade,2 H Miles Prince,1,3 Simon J Harrison1,3 1Department of Haematology, 2Department of Anatomical Pathology, Peter MacCallum Cancer Centre, 3Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC,
Chan KL, Lade S, Prince HM, Harrison SJ
doaj  

Home - About - Disclaimer - Privacy